Growth Metrics

Clorox (CLX) EBIAT (2016 - 2025)

Clorox has reported EBIAT over the past 17 years, most recently at $157.0 million for Q4 2025.

  • Quarterly results put EBIAT at $157.0 million for Q4 2025, down 19.07% from a year ago — trailing twelve months through Dec 2025 was $761.0 million (up 64.01% YoY), and the annual figure for FY2025 was $824.0 million, up 182.19%.
  • EBIAT for Q4 2025 was $157.0 million at Clorox, up from $82.0 million in the prior quarter.
  • Over the last five years, EBIAT for CLX hit a ceiling of $336.0 million in Q2 2025 and a floor of -$209.0 million in Q1 2023.
  • Median EBIAT over the past 5 years was $99.5 million (2021), compared with a mean of $99.9 million.
  • Biggest five-year swings in EBIAT: plummeted 239.33% in 2023 and later skyrocketed 472.0% in 2025.
  • Clorox's EBIAT stood at $72.0 million in 2021, then soared by 37.5% to $99.0 million in 2022, then dropped by 6.06% to $93.0 million in 2023, then soared by 108.6% to $194.0 million in 2024, then dropped by 19.07% to $157.0 million in 2025.
  • The last three reported values for EBIAT were $157.0 million (Q4 2025), $82.0 million (Q3 2025), and $336.0 million (Q2 2025) per Business Quant data.